SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TokyoMex who wrote (14300)5/4/1998 9:38:00 PM
From: Matthew Cooper  Read Replies (1) of 34592
 
Joe, I just wanted to point out a few things about ENMD. I was lucky enough to short it at open around 81 and then cover at 45 today. Then I made and LOST money daytrading it (why can't I just sit still?). I then shorted it again at 53 towards the end. I highly advocate others to do this as well... here's why:

ENMD has just purchased the rights to the new drug. This new drug has shown efficacy in MICE. MICE are NOT HUMANS. I specialize in this area of research (rat/mice/human concordance) and must say the chances of this drug being effective in humans is slim, yet possible. Wall Street severely over-hyped this stock today... I even saw it touted as a "cure" for cancer in several places. This is ridiculous. It is a treatment, not a cure. Even if this drug works in humans (and that is a big "if") it will be several years before we know. The company is strapped for cash and is courting larger drug companies so that they can afford to proceed with the PhaseI, II and II trials. Don't get me wrong, this company has potential, but I see no reason for the $53 evaluation. IMHO, we may see $25 soon.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext